https://www.live-feeds.com/feed/mckesson-and-cd-r-strike-5-8bn-deal-to-buy-infusion-services-providerContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/mckesson-and-cd-r-strike-5-8bn-deal-to-buy-infusion-services-providerhttps://www.live-feeds.com/feed/mckesson-and-cd-r-strike-5-8bn-deal-to-buy-infusion-services-provider#u112169Fri, 09 Oct 2026 13:21:27 +0000Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to acquire at-home infusion therapy provider Option Care Health in a transaction valued at $5.8 billion. Under the terms of the definitive agreement announced on Tuesday, the buyers will take Option Care private at a per-share price of $32.05. The acquisition joins a major healthcare distributor with a leading independent provider of home and alternate-site infusion services. The definitive agreement was signed by CD&R, McKesson Corporation, and Option Care Health, moving the target company from the Nasdaq